Inflammatory bowel disease (IBD), as a global disease, has attracted much research
interest. Constant research has led to a better understanding of the disease condition and …

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is characterized by chronic inflammation, a relapsing and remitting clinical course …

Gut microbial and metabolite alterations have been linked to the pathogenesis of
inflammatory bowel diseases. Here we perform a multi-omics microbiome and metabolite …

Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammation of the
gastrointestinal tract with a highly heterogeneous presentation. It has a relapsing and …

Hematopoietic stem cell transplantation (HSCT) has evolved for> 20 years as a specific
treatment of patients with autoimmune disease (AD). Using European Society for Blood and …

Autoimmune diseases (ADs) represent a heterogenous group of complex diseases with
increasing incidence in Western countries and are a major cause of morbidity …

Background We explored whether stem cell therapy was effective for animal models and
patients with Crohn's disease (CD). Methods We searched five online databases. The …

The introduction of targeted biologic therapies has changed the treatment landscape for
autoimmune diseases (ADs) substantially, but although these therapies provide more …

Spondyloarthritis (SpA) encompasses a heterogeneous group of chronic inflammatory
diseases that can affect both axial and peripheral joints, tendons and entheses. Among the …

Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …